2023 Grover Conference

2023 格罗弗会议

基本信息

批准号：
10753743
负责人：
Anna R Hemnes
金额：
$ 1万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-01 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10753743
关键词：
Address American Animal Model Animal Organ Bioethics Biology Blood Vessels Calendar Cardiopulmonary Caregivers Cell Proliferation Cells Cellular biology Clinic Clinical Clinical Medicine Data Data Analyses Development Diagnosis Disease Environment Epigenetic Process Faculty Functional disorder Funding Future Genes Genetic Genomics Health Inflammatory International Knowledge Leadership Lung Medical Records Mission Molecular Names National Heart, Lung, and Blood Institute North America Outcome Phenotype Postdoctoral Fellow Proteomics Pulmonary Heart Disease Pulmonary Hypertension Research Research Personnel Right Ventricular Dysfunction Right ventricular structure Role Science Scientist Signal Transduction Stress Students Systems Biology Techniques Technology Time United States National Institutes of Health biomarker discovery chronic thromboembolic pulmonary hypertension clinical trial analysis design drug discovery improved interest meetings metabolomics next generation sequencing organ on a chip personalized care posters precision medicine programs pulmonary arterial hypertension pulmonary vascular disorder right ventricular failure rural setting senior faculty symposium tool

项目摘要

The Grover Conference, which is usually held every two years, is the only international meeting in North America that repeatedly focuses on subjects relevant to lung vascular biology, the right ventricle and clinical medicine. Initiated in 1984 under the leadership of the late Dr. John T. “Jack” Reeves, and named in honor of Dr. Robert Grover, the Conference is held in a secluded, rural setting in the Rocky Mountains. The Conference has been continuously refined and refocused in each of the subsequent iterations to include emerging topics such as vascular cell proliferation and biology, lung vascular development, proinflammatory signaling in the pulmonary vasculature, vascular channelopathies, and most recent right ventricular dysfunction in pulmonary vascular disease. The majority of recent Grover Conferences were supported at least in part by the NIH NHLBI R13 funding program. This meeting is unique, because it will bring together scientists interested in precision medicine approaches to pulmonary vascular disease and right heart failure in an environment conducive to interaction and the exchange of ideas among junior and senior investigators and students. In the 2023 calendar year, this will be the only North American conference that will focus completely on the biology of the cardiopulmonary unit. We also believe this meeting is timely and impactful because it will focus on molecular mechanisms and systems biology in the context of understanding cardiopulmonary diseases. We propose a Conference focused on a wide array of genetic, genomic, epigenetic, and related factors relevant to the pathophysiology of pulmonary hypertension and the adaptation of the right ventricle to the stress of pulmonary hypertension. Cutting edge technologies, such as state-of-the-art next generation sequencing techniques and data analysis are included to educate and expand the quickening pace of exciting research in this growing field. Importantly, our proposed agenda includes speakers from highly diverse backgrounds and incorporates junior trainees throughout.

通常每两年举行一次的Grover会议是唯一的国际会议在北美，一再专注于与肺血管生物学相关的主题心室和临床医学。 1984年在已故约翰·T博士的领导下发起。 “杰克”·里夫斯（Jack Reeves 落基山的粗糙环境。会议不断完善，在随后的每个迭代中都重新聚焦，以包括新兴主题，例如血管细胞增殖和生物学，肺血管发育，促炎信号传导肺血管，血管通道病和最新的右心功能障碍在肺血管疾病中。最近的大多数格罗弗会议得到了支持至少部分由NIH NHLBI R13资金计划。这次会议是独一无二的，因为它将将对肺血管的精密医学方法感兴趣的科学家汇集在一起在环境中，疾病和正确的心力衰竭与相互作用和交换初级和高级调查员和学生的想法。在2023日历年中，这将是唯一将完全关注生物学的北美会议心肺单位。我们还认为这次会议是及时和有影响力的，因为它将集中精力关于理解的分子机制和系统生物学心肺疾病。我们提出了一个专注于各种遗传的会议基因组，表观遗传和相关因素与肺的病理生理有关高血压和右心室适应肺动脉高压的应力。最先进的技术，例如最先进的下一代测序技术和包括数据分析以教育和扩大令人兴奋的研究的加快速度这个成长的领域。重要的是，我们提议的Agernda包括来自高度潜水员的演讲者背景并整合了初级学员。